What is the appropriate diagnostic workup and acute and preventive management for hemiplegic migraine?

Hemiplegic Migraine: Diagnostic Workup and Management

For hemiplegic migraine, avoid triptans and ergotamines for acute treatment due to historical contraindications related to vasoconstrictive effects, and instead use NSAIDs (ibuprofen, aspirin) or acetaminophen as first-line acute therapy, while considering lamotrigine, verapamil, acetazolamide, or flunarizine for prevention when attacks occur ≥2 times per month. 1, 2

Diagnostic Workup

Clinical Diagnosis

The diagnosis of hemiplegic migraine is primarily clinical, based on International Classification of Headache Disorders criteria requiring:

• Motor weakness (hemiparesis/hemiplegia) as the defining aura feature
• Additional aura symptoms: visual, sensory, speech impairment, or brainstem manifestations
• Motor symptoms typically lasting <72 hours (though can extend to weeks in severe cases)
• Headache following or accompanying the aura 1, 3, 4

Critical Red Flags to Exclude

Before diagnosing hemiplegic migraine, actively exclude secondary causes 5:

• Atypical aura features suggesting TIA, stroke, epilepsy, or arteriovenous malformations
• Thunderclap headache (subarachnoid hemorrhage)
• Fever or neck stiffness (meningitis, encephalitis)
• Progressive symptoms or altered consciousness
• New onset after age 50

Essential Diagnostic Testing

Neuroimaging is mandatory to exclude structural causes 3, 4:

• MRI brain (preferred over CT) to rule out ischemia, hemorrhage, or structural lesions
• Avoid conventional cerebral angiography - this is contraindicated as it may provoke attacks 2
• CT angiography or MR angiography are safer alternatives if vascular imaging needed

Additional workup 3, 4:

• CSF analysis if infection/inflammation suspected (may show pleocytosis during attacks)
• EEG to exclude epilepsy
• Cardiac evaluation if stroke mimicry present

Genetic Testing

Consider genetic testing for CACNA1A, ATP1A2, and SCN1A mutations 1, 4:

• Can confirm but not exclude diagnosis (only ~75% of familial cases have identified mutations)
• Higher yield when: extensive weakness, brainstem symptoms, cerebellar ataxia, epilepsy, or intellectual disability present
• Distinguishes familial (≥1 first or second-degree relative affected) from sporadic hemiplegic migraine
• Negative genetic testing does not rule out hemiplegic migraine 4

Acute Treatment

First-Line Acute Therapy

NSAIDs and acetaminophen are the safest first-line options 2, 3:

• Ibuprofen 400-800 mg
• Aspirin 900-1000 mg
• Acetaminophen 1000 mg
• Add antiemetics (metoclopramide or domperidone) if nausea/vomiting present 5

Triptan Controversy - Critical Caveat

Triptans are historically contraindicated in hemiplegic migraine due to theoretical vasoconstrictive risks during motor aura 1, 6. However:

• In clinical practice, triptans are often used off-label when NSAIDs fail and headache is severe 1, 2
• No robust evidence proves increased cerebrovascular risk from triptan use in hemiplegic migraine 2
• If prescribed, use only after motor symptoms resolve and for headache phase only
• Document informed consent about off-label use

Absolutely avoid 2, 6:

• Ergotamines (contraindicated)
• Nimodipine (contraindicated)
• Opioids and barbiturates (ineffective, risk of dependency) 5

Management of Prolonged Aura

No effective acute treatment exists for the motor aura itself 2, 3. For severe, prolonged attacks:

• Consider hospitalization for supportive care
• Monitor for complications
• Ensure adequate hydration

Preventive Treatment

When to Initiate Prevention

Start preventive therapy when 2, 3:

• Attack frequency ≥2 per month
• Severe attacks causing significant disability
• Prolonged aura symptoms lasting days to weeks

Preventive Medication Options

First-line preventive agents (no strict hierarchy; trial-and-error approach) 2, 3:

• Flunarizine (calcium channel blocker)
• Verapamil (calcium channel blocker)
• Lamotrigine (particularly effective for aura symptoms)
• Acetazolamide (carbonic anhydrase inhibitor)
• Sodium valproate (avoid in women of childbearing potential) 5

Second-line options 2:

• Topiramate
• Candesartan
• Pizotifen

Beta-blockers (propranolol) are controversial - insufficient evidence of harm to absolutely contraindicate, but use cautiously 2

Emerging Therapies

CGRP monoclonal antibodies show promise 7, 8:

• Fremanezumab, erenumab, galcanezumab
• Growing anecdotal evidence supports efficacy in hemiplegic migraine
• Consider as third-line option when traditional preventives fail 7
• Assess efficacy after 3-6 months of treatment 5

Key Clinical Pitfalls

1. Misdiagnosis as stroke: Hemiplegic migraine is a stroke mimic. Always obtain neuroimaging before diagnosis 9, 10

2. Premature genetic testing interpretation: Negative genetic testing does NOT exclude hemiplegic migraine 4

3. Inappropriate acute treatment: Avoid vasoconstrictors during motor aura phase; if triptans used, only after aura resolves 1

4. Underestimating attack duration: Motor symptoms can last days to weeks, not just hours 3

5. Missing familial cases: Always obtain detailed family history of migraine with motor symptoms 1